Gros David-Alexandre C's Form 4 filing
Eledon Pharmaceuticals, Inc. (ELDN) · filed Aug 4, 2026
- Accession no.
- 0001193125-26-333136
- Filed
- Aug 4, 2026, 5:22 PM ET
- Trade date
- Jul 31, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gros David-Alexandre CCIK 0001644489 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | AGrant or awardAcquired | +354,454 | $0.00 | $0 | 363,454 | Direct | |
| Jul 31, 2026 | Common Stock | FTax withholdingDisposed | −194,791 | $3.38 | −$658,393.58 | 168,663 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.